The Coagulation Labyrinth of Covid-19

The Coagulation Labyrinth of Covid-19 is a guide for clinicians working with acute and sub-acute ARDS cases, covering pathophysiology, laboratory data, clinical aspects, imaging, and therapeutic options. Written during the second wave, it is a unique resource for managing the COVID-19 pandemic.

Format: Paperback / softback
Length: 207 pages
Publication date: 09 December 2022
Publisher: Springer Nature Switzerland AG

This comprehensive book is dedicated to COVID-19-associated coagulopathy, a critical factor in determining mortality. Serving as a guide, it will lead readers on a journey from pathophysiology to laboratory data, clinical aspects, imaging, and therapeutic options. Written in the midst of the second wave, this book stands as the first to address the topic and compile the results of studies and articles published during that time. As such, it serves as a valuable tool for clinicians battling the disease.

The Coagulation Labyrinth of Covid-19 is specifically designed for clinicians specializing in managing acute and sub-acute ARDS cases: intensivists, anesthesiologists, cardiologists, hematologists, and others. It provides an indispensable guide for navigating the challenges posed by the COVID-19 pandemic.

Within its pages, readers will find a wealth of information and insights. The book begins by delving into the underlying mechanisms of COVID-19-associated coagulopathy, exploring the role of inflammation, cytokines, and the immune system in altering coagulation pathways. It then provides a detailed overview of laboratory testing, including the interpretation of D-dimer, prothrombin time, and activated partial thromboplastin time tests, which are crucial in diagnosing and monitoring the condition.

Clinical aspects of COVID-19-associated coagulopathy are extensively covered, encompassing the presentation, diagnosis, and management of patients with coagulopathy. The authors discuss the importance of early recognition and intervention, highlighting the potential risks associated with severe coagulopathy, such as bleeding complications and thrombotic events. They also provide guidance on the use of anticoagulants, thrombolytics, and other therapeutic interventions, tailoring treatment plans to individual patient needs.

Imaging plays a pivotal role in diagnosing and monitoring COVID-19-associated coagulopathy. The book includes comprehensive chapters on imaging techniques, such as ultrasound, computed tomography (CT), and magnetic resonance imaging (MRI). These chapters provide detailed explanations of imaging findings, aiding in the accurate assessment of coagulation disorders and guiding treatment decisions.

Therapeutic options for COVID-19-associated coagulopathy are explored in depth. The authors discuss the use of anticoagulants, such as heparin and warfarin, as well as thrombolytics, such as fibrinolytic agents and platelet inhibitors. They also address the role of immunomodulators, such as corticosteroids and interleukin-6 inhibitors, in managing the disease.

Throughout the book, real-world case studies and clinical vignettes are presented to illustrate the practical application of the information presented. These cases highlight the challenges faced by clinicians and provide valuable insights into effective management strategies.

In conclusion, The Coagulation Labyrinth of Covid-19 is a comprehensive and essential resource for clinicians working with patients affected by COVID-19-associated coagulopathy. Written by experts in the field, this book provides a thorough understanding of the pathophysiology, laboratory testing, clinical aspects, imaging, and therapeutic options associated with this condition. It is an invaluable tool for clinicians striving to provide optimal care for their patients during the pandemic.

Weight: 355g
Dimension: 235 x 155 (mm)
ISBN-13: 9783030829407
Edition number: 1st ed. 2022